Cite
HARVARD Citation
Jackson, G. et al. (2021). Optimising the value of immunomodulatory drugs during induction and maintenance in transplant ineligible patients with newly diagnosed multiple myeloma: results from Myeloma XI, a multicentre, open‐label, randomised, Phase III trial. British journal of haematology. pp. 853-868. [Online].